PrescriptionDrugs.org

Amphetamine/Dextroamphetamine

Brand names: Adderall, Adderall XR

CNS StimulantsSchedule II

Key Takeaway

Adderall is a brand name for a combination of amphetamine and dextroamphetamine salts, FDA-approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. As a Schedule II controlled substance, it has a high potential for abuse and dependence. It improves focus and attention by increasing dopamine and norepinephrine activity in the brain.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Controlled Substance — DEA Schedule II

Amphetamine/Dextroamphetamine is a federally controlled substance. It has potential for abuse and dependence. Your prescriber will monitor you while taking this medication.

If you or someone you know is struggling with substance use, call the SAMHSA National Helpline: 1-800-662-4357 (free, confidential, 24/7).

How does Amphetamine/Dextroamphetamine work?

Adderall contains a mixture of four amphetamine salts — amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate — in a 3:1 ratio of dextroamphetamine to levoamphetamine [1, 2]. These compounds belong to the stimulant class of medications and work by increasing the levels of two key neurotransmitters in the brain: dopamine and norepinephrine [1, 15].

In a person with ADHD, the brain's prefrontal cortex — the region responsible for executive functions like attention, impulse control, and planning — tends to have lower-than-typical levels of dopamine and norepinephrine [15]. This relative deficit makes it harder to sustain attention, organize tasks, and regulate behavior.

Adderall works through two primary mechanisms [1, 7, 15]. First, it enters nerve terminals and causes the release of stored dopamine and norepinephrine into the synaptic cleft (the gap between neurons). Second, it blocks the reuptake transporters that normally recycle these neurotransmitters back into the nerve terminal. The combined effect is a significant increase in dopamine and norepinephrine signaling in the prefrontal cortex and other brain regions.

This enhanced neurotransmitter activity improves the brain's ability to filter distractions, sustain focus on tasks, and control impulses [15]. Unlike caffeine (which provides non-specific stimulation), amphetamines target the specific neurochemical pathways involved in attention regulation [7].

Adderall immediate-release (IR) begins working within 30-60 minutes and lasts approximately 4-6 hours [1]. Adderall XR (extended-release) uses a bead-based delivery system that releases half the dose immediately and the other half about 4 hours later, providing approximately 10-12 hours of coverage [2]. Meta-analyses have confirmed amphetamine-based stimulants as among the most effective treatments for ADHD across age groups [6].

What to expect when starting Amphetamine/Dextroamphetamine

When you first start Adderall, you will typically notice improved focus, concentration, and attention within 30-60 minutes of taking a dose [1, 2]. Many people describe this as a sense of mental clarity — distractions become easier to ignore, and tasks that previously felt overwhelming become more manageable [15].

During the first few days, you may also experience decreased appetite, dry mouth, and mild increases in heart rate or blood pressure [1]. These effects are usually most noticeable at the beginning of treatment and may lessen over the first 1-2 weeks as your body adjusts.

Your doctor will start you on a low dose and adjust it gradually (typically every week) until the best balance of symptom control and side effects is achieved [1, 2]. Finding the right dose is a process that may take several weeks. Meta-analyses suggest that optimal dosing is highly individual and should be titrated based on clinical response [6].

Some people notice that the medication works very well for the first few weeks and then seems less effective. This is known as tolerance and should be discussed with your doctor rather than self-adjusting your dose [12]. Your doctor may adjust the dose, switch formulations (IR to XR or vice versa), or try a medication holiday.

Adderall can interfere with sleep, especially if taken later in the day [1, 2]. Take IR doses at least 4-6 hours before bedtime, and take XR in the morning. Report any sleep difficulties to your prescriber.

Because Adderall is a Schedule II controlled substance [4], your prescription cannot be called in by phone in most states and cannot be refilled — you need a new prescription each month. The FDA has provided updates on stimulant medication shortages that may affect availability [8].

What are the common side effects of Amphetamine/Dextroamphetamine?

Common

Common(12 effects)
  • Decreased appetite22-36%
  • Insomnia12-27%
  • Dry mouth7-35%
  • Headache3-26%
  • Nausea5-8%
  • Abdominal pain10-14% in children
  • Weight loss4-11%
  • Nervousness/anxiety6-13%
  • Irritability3-9%
  • Dizziness2-7%
  • Increased heart rate5-10%
  • Emotional lability/mood swings2-9%

What are the serious side effects of Amphetamine/Dextroamphetamine?

Serious

Serious(8 effects)
  • Sudden cardiac death/serious cardiovascular eventsVery rare; increased risk in patients with structural cardiac abnormalities
  • Stroke and myocardial infarctionVery rare in adults
  • New or worsening psychiatric symptoms (psychosis, mania)<1%; higher risk with pre-existing conditions
  • Peripheral vasculopathy (Raynaud phenomenon)Uncommon
  • Growth suppression in children1-2 cm height reduction over 3 years in some studies
  • Serotonin syndrome (with serotonergic drugs)Rare; risk increases with SSRIs, SNRIs, MAOIs
  • SeizuresVery rare
  • RhabdomyolysisVery rare

What drugs interact with Amphetamine/Dextroamphetamine?

  • Major
    MAO inhibitors (selegiline, phenelzine, tranylcypromine) Concurrent use or use within 14 days of an MAOI is contraindicated. The combination can cause hypertensive crisis, hyperthermia, seizures, and death due to excessive catecholamine release.
  • Major
    Serotonergic drugs (SSRIs, SNRIs, triptans) Amphetamines have mild serotonergic activity. When combined with SSRIs, SNRIs, or other serotonergic drugs, there is a risk of serotonin syndrome — symptoms include agitation, tremor, hyperthermia, and muscle rigidity. Monitor closely.
  • Moderate
    Acidifying agents (ascorbic acid, fruit juices) Urinary acidifiers and acidic foods/beverages can increase renal excretion of amphetamines, reducing their effectiveness. Avoid large amounts of vitamin C or acidic juices around the time of dosing.
  • Moderate
    Alkalinizing agents (sodium bicarbonate, antacids) Urinary alkalinizers decrease renal excretion of amphetamines, potentially increasing blood levels and the risk of side effects. Use with caution.
  • Moderate
    CYP2D6 inhibitors (fluoxetine, paroxetine, bupropion) CYP2D6 inhibitors can increase amphetamine exposure by reducing hepatic metabolism. Monitor for increased stimulant effects. Dose adjustment may be needed.
  • Moderate
    Antihypertensive medications Amphetamines can increase blood pressure, potentially reducing the effectiveness of antihypertensive drugs. Monitor blood pressure closely and adjust antihypertensive doses as needed.
  • Moderate
    Proton pump inhibitors (omeprazole, pantoprazole) PPIs increase gastric pH, which may increase the absorption and bioavailability of amphetamines. This can lead to enhanced stimulant effects. Monitor for signs of overstimulation.
  • Moderate
    Tricyclic antidepressants Amphetamines may enhance the effects of tricyclic antidepressants by increasing norepinephrine levels. The combination may increase the risk of cardiovascular effects. Use with caution and monitor.

View all drug interactions →

Can I eat certain foods or drink alcohol with Amphetamine/Dextroamphetamine?

Adderall can be taken with or without food [1, 2]. Taking it with food may reduce stomach upset but can also slightly delay onset of action.

Acidic foods and drinks: Avoid acidic foods and drinks (orange juice, grapefruit juice, vitamin C supplements) around the time of dosing, as acidic conditions can reduce absorption and increase urinary excretion of amphetamines, potentially reducing effectiveness [1]. Urinary pH significantly affects amphetamine elimination — acidic urine accelerates excretion while alkaline urine slows it [1, 7].

Alcohol: Avoid alcohol [1]. Alcohol can mask the stimulant effects of Adderall, increasing the risk of overconsumption of alcohol. The combination also increases cardiovascular stress and impairs judgment [12].

Caffeine: Caffeine combined with Adderall can increase heart rate, blood pressure, and anxiety [12]. While moderate caffeine intake may be acceptable for some people, discuss it with your prescriber. Reduce or eliminate caffeine if you experience palpitations, anxiety, or insomnia.

What is the typical dosage for Amphetamine/Dextroamphetamine?

Adderall IR (immediate-release) for ADHD [1]: - Children (3-5 years): Start 2.5 mg daily, increase by 2.5 mg/week - Children (6+ years): Start 5 mg once or twice daily, increase by 5 mg/week - Adults: Start 5 mg once or twice daily. Typical effective dose: 5-40 mg/day in divided doses. Maximum: 40 mg/day - Give first dose upon awakening; subsequent doses at 4-6 hour intervals

Adderall XR (extended-release) for ADHD [2]: - Children (6-12 years): Start 5-10 mg once daily in the morning, increase by 5-10 mg/week. Maximum: 30 mg/day - Adolescents (13-17): Start 10 mg once daily. Maximum: 20 mg/day - Adults: Start 20 mg once daily in the morning. Maximum: typically 60 mg/day (off-label higher doses used under supervision) - Capsules may be opened and beads sprinkled on applesauce — do not crush or chew beads [2]

Narcolepsy (IR only) [1]: - Adults and children 12+: Start 10 mg/day, increase by 10 mg/week. Usual dose: 5-60 mg/day in divided doses - Children 6-12: Start 5 mg/day, increase by 5 mg/week

Important notes: Take the last daily dose of IR by early afternoon to minimize insomnia [1]. XR should be taken in the morning [2]. Drug holidays (weekend or summer breaks) may be considered to manage side effects and assess ongoing need, though evidence on their long-term impact is mixed [10, 12].

How much does Amphetamine/Dextroamphetamine cost?

Generic mixed amphetamine salts (generic Adderall) are available from multiple manufacturers and are significantly less expensive than brand-name Adderall [9, 11].

Generic Adderall IR typically costs $15-$40 for a 30-day supply at most pharmacies. Generic Adderall XR (extended-release) typically costs $25-$60 [11]. Brand-name Adderall XR can cost $300-$400+ without insurance.

GoodRx and other discount programs can reduce cash prices by 50-80% [11]. Always compare prices across pharmacies, as costs can vary significantly.

As a Schedule II controlled substance [4], Adderall cannot use manufacturer copay cards in most programs. However, Teva (maker of authorized generic Adderall) offers limited patient assistance.

Most insurance plans cover generic mixed amphetamine salts, though prior authorization may be required [11]. Many plans require trying generic IR before covering XR. Step therapy requirements are common.

If you are uninsured, community health centers and some pharmacy discount programs can help reduce costs. NeedyMeds.org maintains a list of assistance programs for ADHD medications. The FDA has acknowledged stimulant shortages that may affect pricing and availability [8].

Is Amphetamine/Dextroamphetamine safe during pregnancy or breastfeeding?

Pregnancy: Amphetamines are classified as FDA Pregnancy Category C [1, 2]. Animal studies have shown adverse effects on embryo-fetal development. Human data from observational studies suggest a possible small increased risk of preterm birth, low birth weight, and neonatal withdrawal symptoms [1]. Infants born to mothers dependent on amphetamines may experience withdrawal symptoms (agitation, feeding difficulties, excessive crying) [1, 12]. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Discuss ADHD management options with your healthcare provider if you are pregnant or planning to become pregnant.

Breastfeeding: Amphetamines are excreted in breast milk [1]. The relative infant dose is estimated at 2-6% of the weight-adjusted maternal dose. Potential effects on the nursing infant include irritability, poor feeding, poor weight gain, and insomnia [1, 12]. The decision to breastfeed while taking Adderall should weigh the benefit of treatment against the potential risk to the infant. If used, monitor the infant for agitation and poor growth.

Is there a generic version of Amphetamine/Dextroamphetamine?

Generic mixed amphetamine salts are available from multiple manufacturers and are FDA-rated as therapeutically equivalent (AB-rated) to brand-name Adderall and Adderall XR [9]. For most patients, there is no clinically meaningful difference between the generic and brand-name products.

Some patients report subjective differences between different generic manufacturers [12]. While all generics must meet FDA bioequivalence standards, the inactive ingredients (fillers, dyes, binders) may differ, and some patients may be sensitive to these differences. If you experience a change in effectiveness after switching manufacturers, discuss it with your pharmacist — they may be able to consistently stock from one manufacturer.

Authorized generic Adderall XR (manufactured by Teva under agreement with Shire/Takeda) is identical to the brand-name product in both active and inactive ingredients [9].

The CDC reports that approximately 6 million U.S. children aged 3-17 years have been diagnosed with ADHD, making stimulant medications among the most prescribed drugs in the country [14].

For Caregivers

If you care for a child or teen taking Adderall, maintain regular follow-up appointments to monitor growth (height and weight), heart rate, blood pressure, and behavioral response [1, 2, 14].

Watch for appetite suppression — many children eat very little during the day when the medication is active [1]. Consider offering a good breakfast before the medication kicks in and a nutritious dinner/evening snack after it wears off.

Monitor mood and behavior, particularly in the late afternoon/evening as the medication wears off [12]. Some children experience 'rebound' — a period of irritability, emotional sensitivity, or hyperactivity as the drug leaves their system.

Keep Adderall in a secure, locked location. It is a Schedule II controlled substance with high potential for diversion and misuse, particularly in school and college settings [4, 13]. Educate your child about never sharing their medication.

Watch for signs of misuse: taking more than prescribed, running out early, requesting early refills, or significant behavioral changes [4, 6]. Also watch for new onset of tics, psychotic symptoms (hearing or seeing things), or extreme mood changes — report these to the prescriber immediately [1, 2]. The MTA study follow-up provides important context on long-term outcomes of stimulant treatment in children [10].

Frequently asked questions about Amphetamine/Dextroamphetamine

References

  1. [Regulatory] Adderall (mixed salts of a single-entity amphetamine product) prescribing information. Teva Pharmaceuticals. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011522s047lbl.pdf Accessed 2025-01-15.
  2. [Regulatory] Adderall XR (mixed salts of a single-entity amphetamine product extended-release capsules) prescribing information. Takeda/Shire. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s040lbl.pdf Accessed 2025-01-15.
  3. [Regulatory] Amphetamine/dextroamphetamine. National Library of Medicine DailyMed drug label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f35e86f4-3421-4d39-a67d-7e35a3e1e14c Accessed 2025-01-15.
  4. [Regulatory] DEA Drug Fact Sheet: Amphetamines. https://www.dea.gov/factsheets/amphetamines Accessed 2025-01-15.
  5. [Regulatory] Faraone SV, Biederman J, Spencer TJ, Aleardi M. Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed. 2006;8(4):4. https://pubmed.ncbi.nlm.nih.gov/11845579/ Accessed 2025-01-15.
  6. [Regulatory] Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-738. https://pubmed.ncbi.nlm.nih.gov/26466378/ Accessed 2025-01-15.
  7. [Regulatory] Heal DJ, Smith SL, Gosden J, Nutt DJ. Amphetamine, past and present — a pharmacological and clinical perspective. J Psychopharmacol. 2013;27(6):479-496. https://pubmed.ncbi.nlm.nih.gov/17846363/ Accessed 2025-01-15.
  8. [Regulatory] FDA updates on stimulant medication shortages. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-patients-and-health-care-professionals-about-adderall-shortage Accessed 2025-01-15.
  9. [Regulatory] Drugs@FDA: FDA-Approved Drugs — Adderall NDA 011522. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011522 Accessed 2025-01-15.
  10. [Regulatory] Swanson JM, Arnold LE, Molina BSG, et al. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2017;78(2):e149-e156. https://pubmed.ncbi.nlm.nih.gov/23796946/ Accessed 2025-01-15.
  11. [Observational] GoodRx. Adderall Prices, Coupons & Savings Tips. https://www.goodrx.com/adderall Accessed 2025-01-15.
  12. [Regulatory] UpToDate. Dextroamphetamine and amphetamine: Drug information. Wolters Kluwer. https://www.uptodate.com/contents/dextroamphetamine-and-amphetamine-drug-information Accessed 2025-01-15.
  13. [Regulatory] Lakhan SE, Kirchgessner A. Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain Behav. 2012;2(5):661-677. https://pubmed.ncbi.nlm.nih.gov/20008702/ Accessed 2025-01-15.
  14. [Clinical] CDC. Attention-Deficit/Hyperactivity Disorder (ADHD): Data & Statistics. https://www.cdc.gov/ncbddd/adhd/data.html Accessed 2025-01-15.
  15. [Regulatory] Faraone SV. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev. 2018;87:255-270. https://pubmed.ncbi.nlm.nih.gov/29388179/ Accessed 2025-01-15.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: